Know Cancer

or
forgot password
  • cancer clinical trials in alabama

  • DNA Variations in the Gene in Young Patients With Wilms' Tumor
    University of South Alabama Cancer Research Institute
    Mobile, Alabama 36604
    Kidney Cancer
    Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Breast Cancer
    Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Bladder Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Northeast Alabama Regional Medical Center

    Trial Locations
    Northeast Alabama Regional Medical Center
    Huntsville Hospital
    MBCCOP - Gulf Coast
    University of South Alabama Mitchell Cancer Institute
    East Alabama Medical Center
    Colorectal Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    UAB Comprehensive Cancer Center

    Trial Locations
    UAB Comprehensive Cancer Center
    University of South Alabama Mitchell Cancer Institute
    Leukemia
    Study of REN-1654 in Patients With Sciatica Pain
    Alabama Clinical Therapeutics
    Birmingham, Alabama 35235
    Sciatica, Herniated Disc, Radiculopathy
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Recurrent Mantle Cell Lymphoma
    131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Malignant Glioma, Glioblastoma Multiforme, GBM, Anaplastic Astrocytoma, Oligo-Astrocytoma, Gliosarcoma
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Providence Cancer Center at Providence Hospital
    Mobile, Alabama 36608
    Breast Cancer
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Myeloid Leukemia, Chronic, Chronic-Phase
    Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Myeloid Leukemia, Chronic, Accelerated Phase, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    Northwest Alabama Cancer Center, PC
    Florence, Alabama 35630
    Chronic Lymphocytic Leukemia
    Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
    Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
    Birmingham, Alabama 35294
    Liver Cancer
    Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
    VA Medical Center, Birmingham
    Birmingham, Alabama 35233
    Prostate Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    University of Alabama at Birmingham
    Birmingham, Alabama 35294-3300
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Birmingham Hematology and Oncology Associates, LLC

    Trial Locations
    Birmingham Hematology and Oncology Associates, LLC
    Oncology Specialties, P.C.
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Cervical Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Northeast Alabama Regional Medical Center

    Trial Locations
    Northeast Alabama Regional Medical Center
    University of Alabama at Birmingham
    Clearview Cancer Institute
    Mobile Infirmary Medical Center
    Providence Hospital
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Radiation Therapy in Treating Young Patients With Gliomas
    UAB Comprehensive Cancer Center
    Birmingham, Alabama 35294
    Brain Tumor, Central Nervous System Tumor
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham
    Birmingham, Alabama 35294
    Fallopian Tube Cancer, Ovarian Cancer
    Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
    Birmingham Hematology and Oncology Associates

    Trial Locations
    Birmingham Hematology and Oncology Associates
    Comprehensive Cancer Institute
    Breast Cancer
    Once Weekly Radiation for Lung Cancer With Chemotherapy
    Cancer Center and Mobile Infirmary Hospital
    Mobile, Alabama 36607
    Carcinoma, Non-Small-Cell Lung
    Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy
    Mobile Infirmary Medical Center

    Trial Locations
    Mobile Infirmary Medical Center
    Providence Hospital,
    Carcinoma, Non-Small-Cell Lung
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Mobile Infirmary Medical Center
    Mobile, Alabama 36640-0460
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Northeast Alabama Regional Medical Center

    Trial Locations
    Northeast Alabama Regional Medical Center
    University of Alabama at Birmingham
    Clearview Cancer Institute
    Mobile Infirmary Medical Center
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia
    Comprehensive Cancer Center at University of Alabama at Birmingham
    Birmingham, Alabama 35294
    Leukemia
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Children's Hospital of Alabama
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    University of Alabama at Birmingham

    Trial Locations
    University of Alabama at Birmingham
    Mobile Infirmary Medical Center
    University of South Alabama Mitchell Cancer Institute
    Providence Hospital
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer